| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $527K | -77.0% |
| R&D Expense | $6.3M | +280.7% |
| SG&A Expense | $14.7M | -8.0% |
| Operating Income | -$22.3M | -23.3% |
| Interest Expense | $1.4M | +132.2% |
| Pre-tax Income | -$23.7M | -34.1% |
| Income Tax | $8K | -63.5% |
| Net Income | -$24.2M | -37.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $262K | +90.0% |
| Current Assets | $4.3M | -37.2% |
| Total Assets | $9.4M | -32.2% |
| Current Liabilities | $1.2M | -57.4% |
| Long-term Debt | $135K | +8475.4% |
| Total Liabilities | $9.1M | +209.8% |
| Stockholders' Equity | $284K | -97.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.8M | -46.0% |
| Capital Expenditures | $300K | +232.7% |
| Investing Cash Flow | -$182K | -56.1% |
| Financing Cash Flow | $10.2M | -7.7% |
| Free Cash Flow | -$13.1M | -47.9% |